Funding news
Waypoint Bio logo

Waypoint Bio Closes $20.0

Recently funded · $20.0M Series aHospitals and Health CareUSView source

Get the full Waypoint Bio company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The fight against solid tumors just got a $20.0M boost, with Waypoint Bio announcing its Series A funding round close. The VC-backed biotech startup is focused on building the next generation of cell therapies, aiming to tackle some of oncology's most challenging targets.

The investment round saw participation from a strong syndicate of firms, including Amplify Partners, General Catalyst, Time BioVentures, Lux Capital, and Hummingbird Ventures. Waypoint Bio's mission centers on developing advanced therapeutic solutions in this critical area.

Capchase, an NYC-based B2B financing startup, raised $26 million in equity funding. 01 Advisors led, joined by Caffeinated Capital, Thomvest Ventures, Scifi VC, Bling Capital, and Invesco. It also secured a $174 million credit facility.

Daloopa, an NYC-based provider of source-linked financial data for investment firms, raised $47 million in Series C funding. Brighton Park Capital led the round, joined by Squarepoint Capital, Touring Capital, and Nexus Venture Partners. Solstice, an NYC-based AI-native marketing agency for pharma brands, raised $21 million in Series A funding. Transformation Capital led the round and was joined

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Default logo

Default

United States

$20.0M
2
Abstract logo

Abstract

United States

$59.0M
3
Pacifico Biolabs logo

Pacifico Biolabs

Germany

€7.0M
4
Secretome Therapeutics logo

Secretome Therapeutics

United States

$30.0M
5
Solstice logo

Solstice

United States

$21.0M